Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
Small TN, Young JW, Castro-Malaspina H, Prockop S, Wilton A, Heller G, Boulad F, Chiu M, Hsu K, Jakubowski A, Kernan NA, Perales MA, O'Reilly RJ, Papadopoulos EB. Small TN, et al. Among authors: kernan na. Biol Blood Marrow Transplant. 2007 Feb;13(2):235-44. doi: 10.1016/j.bbmt.2006.10.005. Biol Blood Marrow Transplant. 2007. PMID: 17241929 Free article. Clinical Trial.
Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease.
Perales MA, Ishill N, Lomazow WA, Weinstock DM, Papadopoulos EB, Dastigir H, Chiu M, Boulad F, Castro-Malaspina HR, Heller G, Jakubowski AA, O'Reilly RJ, Small TN, Young JW, Kernan NA. Perales MA, et al. Among authors: kernan na. Bone Marrow Transplant. 2007 Sep;40(5):481-6. doi: 10.1038/sj.bmt.1705762. Epub 2007 Jul 9. Bone Marrow Transplant. 2007. PMID: 17618322
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.
Chewning JH, Castro-Malaspina H, Jakubowski A, Kernan NA, Papadopoulos EB, Small TN, Heller G, Hsu KC, Perales MA, van den Brink MR, Young JW, Prockop SE, Collins NH, O'Reilly RJ, Boulad F. Chewning JH, et al. Among authors: kernan na. Biol Blood Marrow Transplant. 2007 Nov;13(11):1313-23. doi: 10.1016/j.bbmt.2007.07.006. Epub 2007 Sep 7. Biol Blood Marrow Transplant. 2007. PMID: 17950918 Free article. Clinical Trial.
Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
van Burik JA, Carter SL, Freifeld AG, High KP, Godder KT, Papanicolaou GA, Mendizabal AM, Wagner JE, Yanovich S, Kernan NA. van Burik JA, et al. Among authors: kernan na. Biol Blood Marrow Transplant. 2007 Dec;13(12):1487-98. doi: 10.1016/j.bbmt.2007.08.049. Biol Blood Marrow Transplant. 2007. PMID: 18022579 Free article. Clinical Trial.
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.
Perales MA, Jenq R, Goldberg JD, Wilton AS, Lee SS, Castro-Malaspina HR, Hsu K, Papadopoulos EB, van den Brink MR, Boulad F, Kernan NA, Small TN, Wolden S, Collins NH, Chiu M, Heller G, O'Reilly RJ, Kewalramani T, Young JW, Jakubowski AA. Perales MA, et al. Among authors: kernan na. Bone Marrow Transplant. 2010 Sep;45(9):1408-16. doi: 10.1038/bmt.2009.371. Epub 2010 Jan 11. Bone Marrow Transplant. 2010. PMID: 20062091 Free PMC article.
Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.
Barker JN, Byam CE, Kernan NA, Lee SS, Hawke RM, Doshi KA, Wells DS, Heller G, Papadopoulos EB, Scaradavou A, Young JW, van den Brink MR. Barker JN, et al. Among authors: kernan na. Biol Blood Marrow Transplant. 2010 Nov;16(11):1541-8. doi: 10.1016/j.bbmt.2010.08.011. Epub 2010 Aug 25. Biol Blood Marrow Transplant. 2010. PMID: 20800103 Free PMC article.
T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies.
Jakubowski AA, Small TN, Kernan NA, Castro-Malaspina H, Collins N, Koehne G, Hsu KC, Perales MA, Papanicolaou G, van den Brink MR, O'Reilly RJ, Young JW, Papadopoulos EB. Jakubowski AA, et al. Among authors: kernan na. Biol Blood Marrow Transplant. 2011 Sep;17(9):1335-42. doi: 10.1016/j.bbmt.2011.01.005. Epub 2011 Jan 11. Biol Blood Marrow Transplant. 2011. PMID: 21232623 Free PMC article. Clinical Trial.
190 results